Ministry of Health ServicesGoverment of British Columbia
Pharmacare Program
| Home | SA Criteria | SA Forms | RDP | LCA |
H2 Blocker Drugs - Special Authority Criteria

Generic Name / Strength / Form
nizatidine

Criteria Approval Period
1. Treatment failure or intolerance to cimetidine.1. Indefinite

OR

2. Concurrent treatment with warfarin, phenytoin or theophylline. 2. First approval: One year

Renewals: One year

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • None

Online Form (PDF)
Click on the link to complete a special authority request form.

PDF Format

Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon. Get Acrobat Reader Icon

Last Revised: June 21, 2006

blank
    space for alignment
Go to TopGo to CopyrightGo to DisclaimerGo to Privacy StatementGo to Feedback Form
blank space for alignment blank space for alignment blank
    space for alignment blank space for alignment blank space for alignment blank space for alignment